β‐synuclein aggregates and induces neurodegeneration in dopaminergic neurons

Abstract

Our results suggest that the role of β-synuclein as a putative modulator of neuropathology in aggregopathies like Parkinson disease and dementia with Lewy bodies needs to be revisited.